To lower drug costs, define ‘cost’ to mean net cost after rebates
By Sean Dickson In what could be a turning point in the prescription drug debate, President Biden has made clear that the health crisis of unaffordable medications must end. In…
Intentionally Delayed Pharmaceutical Innovation Under Perverse Incentives: Gilead’s HIV Pipeline As A Case Study
By Sean Dickson and Amy Killelea As Congress continues its attention to pharmaceutical development and prices, the U.S. Senate Committee on Finance’s Subcommittee on Fiscal Responsibility and Economic Growth has…
Limiting Coverage Based On Efficacy And Safety: A Path Forward For Medicare Regarding The Alzheimer’s Treatment Aducanumab
By Sean Dickson, Amy Killelea, Richard G. Frank Today, the Food & Drug Administration (FDA) will announce a decision on whether to approve the biologic aducanumab, intended to alleviate symptoms…
The Road to a COVID-19 Vaccination Is a Bumpy One for Many Older Adults
By Timothy Lash As the United States passes the grim and staggering milestone of 500,000 deaths from COVID-19, there is increasing hope that vaccines may soon help us reduce this…
Our Approach: Private Sector Principles for Results-Driven Philanthropy
West Health’s CEO, Shelley Lyford, describes our unique approach to the mission of successful aging. For West Health, addressing the needs of seniors isn’t simply a fiscal and political priority…
